Colgate-Palmolive Company Company Profile (NYSE:CL)

About Colgate-Palmolive Company (NYSE:CL)

Colgate-Palmolive Company logoColgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company's oral care products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh and Colgate Optic White. The Company is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. The Company manufactures and markets a range of products for the home care market, including Palmolive and Ajax dishwashing liquids, Fabuloso and Ajax household cleaners and Murphy's Oil Soap. The Company, through its Hill's Pet Nutrition segment (Hill's), manufactures pet nutrition products for dogs and cats.

Industry, Sector and Symbol:
  • Sector: Consumer Staples
  • Industry: Personal Products
  • Sub-Industry: Household Products
  • Symbol: NYSE:CL
  • CUSIP: 19416210
  • Web:
  • Market Cap: $63.7 billion
  • Outstanding Shares: 880,841,000
Average Prices:
  • 50 Day Moving Avg: $72.81
  • 200 Day Moving Avg: $73.23
  • 52 Week Range: $63.43 - $77.27
  • Trailing P/E Ratio: 26.87
  • Foreward P/E Ratio: 23.11
  • P/E Growth: 3.33
Sales & Book Value:
  • Annual Revenue: $15.18 billion
  • Price / Sales: 4.20
  • Book Value: ($0.28) per share
  • Price / Book: -258.29
  • Annual Dividend: $1.60
  • Dividend Yield: 2.1%
  • EBITDA: $4.42 billion
  • Net Margins: 15.83%
  • Return on Equity: 3,121.95%
  • Return on Assets: 20.57%
  • Debt-to-Equity Ratio: 73.93%
  • Current Ratio: 1.21%
  • Quick Ratio: 0.89%
  • Average Volume: 3.00 million shs.
  • Beta: 0.81
  • Short Ratio: 2.75

Frequently Asked Questions for Colgate-Palmolive Company (NYSE:CL)

What is Colgate-Palmolive Company's stock symbol?

Colgate-Palmolive Company trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

How often does Colgate-Palmolive Company pay dividends? What is the dividend yield for Colgate-Palmolive Company?

Colgate-Palmolive Company announced a quarterly dividend on Tuesday, September 26th. Shareholders of record on Monday, October 23rd will be given a dividend of $0.40 per share on Wednesday, November 15th. This represents a $1.60 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date is Friday, October 20th. View Colgate-Palmolive Company's Dividend History.

How were Colgate-Palmolive Company's earnings last quarter?

Colgate-Palmolive Company (NYSE:CL) posted its earnings results on Thursday, July, 28th. The company reported $0.70 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.69 by $0.01. The firm earned $3.85 billion during the quarter, compared to the consensus estimate of $3.86 billion. Colgate-Palmolive Company had a return on equity of 3,121.95% and a net margin of 15.83%. The company's revenue for the quarter was down 5.4% on a year-over-year basis. During the same period last year, the business posted $0.70 EPS. View Colgate-Palmolive Company's Earnings History.

When will Colgate-Palmolive Company make its next earnings announcement?

Colgate-Palmolive Company is scheduled to release their next quarterly earnings announcement on Friday, October, 27th 2017. View Earnings Estimates for Colgate-Palmolive Company.

Where is Colgate-Palmolive Company's stock going? Where will Colgate-Palmolive Company's stock price be in 2017?

16 brokerages have issued 1 year price targets for Colgate-Palmolive Company's stock. Their forecasts range from $68.00 to $85.00. On average, they expect Colgate-Palmolive Company's stock price to reach $76.38 in the next twelve months. View Analyst Ratings for Colgate-Palmolive Company.

What are analysts saying about Colgate-Palmolive Company stock?

Here are some recent quotes from research analysts about Colgate-Palmolive Company stock:

  • 1. According to Zacks Investment Research, "Colgate has outperformed the industry in the past month. We remain encouraged by the progress on its 2012 Restructuring Program and expect additional opportunities identified under the program to help reach the higher end of its previously stated cost and savings view. Moreover, the company has been infamous among investors with its meet or beat earnings track record. However, the company’s sales missed expectations for the fifth straight quarter in second-quarter due to continued softness in North America and challenges in Asia-Pacific. Further, the company lagged sales estimates in 16 out of the trailing 17 quarters. Nevertheless, the company remains focused on four fundamentals to boost profits including, increased spending on advertisements; innovation across portfolio; higher spends on e-commerce business and aggressively maximizing productivity. Also, its disciplined capital strategy bodes well. Estimates have been stable lately." (10/17/2017)
  • 2. Morgan Stanley analysts commented, "Our new $84 PT is based on ~24.5x times our upwardly revised FY19 EPS estimate (~23xex a 7.5% strategic halo), representing a ~20% return with a ~2% dividend yield," the firm said."Furthermore, we see a 2:1 ratio of bull case upside relative to bear case downside." (9/25/2017)
  • 3. Jefferies Group LLC analysts commented, "Late Tues. (5/16), the NY Post reported that CL Chair/CEO Ian Cook recently told investors he would consider selling the company for $100/share (~19.5x EV/EBITDA). While we have no knowledge of any potential M&A or the specific accuracy of this report, this strikes us as a reasonable price (for both a potential buyer and for CL as sellers). We view JNJ as the most likely acquirer, followed by ULVR and KHC/3G. Valuation remains nearly full, reit. $76 PT, Hold. CL CEO/Chairman Ian Cook reportedly would consider selling for $100/share: Late Tuesday, the NY Post reported the Ian Cook, Colgate’s Chairman and CEO, recently signaled he would be open to selling the company… for $100/share", while at a meeting with institutional investors. The Post further noted recent speculation the CL is being stalked by" Unilever and pointed to activist Nelson Peltz’s stake in P&G as a potential spark for sector consolidation." (5/17/2017)

Who are some of Colgate-Palmolive Company's key competitors?

Who are Colgate-Palmolive Company's key executives?

Colgate-Palmolive Company's management team includes the folowing people:

  • Ian M. Cook, Chairman of the Board, President, Chief Executive Officer
  • Daniel B. Marsili, Chief Human Resource Officer
  • John J. Huston, Senior Vice President - Chief of Staff
  • Patricia Verduin Ph.D., Chief Technology Officer
  • Mukul V. Deoras, Chief Marketing Officer
  • Henning I. Jakobsen, Vice President, Corporate Controller
  • Victoria L. Dolan, Chief Transformation Officer
  • Delia H. Thompson, Chief Investor Relations Officer
  • Makarand Karnataki, Company Secretary and Compliance Officer
  • Jennifer M. Daniels, Chief Legal Officer and Secretary

Who owns Colgate-Palmolive Company stock?

Colgate-Palmolive Company's stock is owned by a number of of institutional and retail investors. Top institutional investors include Robeco Institutional Asset Management B.V. (0.08%), PGGM Investments (0.06%), Shell Asset Management Co. (0.04%), Fisher Asset Management LLC (0.03%), Wendell David Associates Inc. (0.02%) and Ingalls & Snyder LLC (0.02%). Company insiders that own Colgate-Palmolive Company stock include Daniel B Marsili, Delano E Lewis, Delia H Thompson, Dennis J Hickey, Ellen M Hancock, Fabian T Garcia, Franck J Moison, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive Company.

Who sold Colgate-Palmolive Company stock? Who is selling Colgate-Palmolive Company stock?

Colgate-Palmolive Company's stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Private Asset Management Inc., Bridges Investment Counsel Inc., Neville Rodie & Shaw Inc., Family Capital Trust Co, Ingalls & Snyder LLC, Wendell David Associates Inc. and Park National Corp OH. Company insiders that have sold Colgate-Palmolive Company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Patricia Verduin, Richard J Kogan and Stephen I Sadove. View Insider Buying and Selling for Colgate-Palmolive Company.

Who bought Colgate-Palmolive Company stock? Who is buying Colgate-Palmolive Company stock?

Colgate-Palmolive Company's stock was bought by a variety of institutional investors in the last quarter, including Shell Asset Management Co., Assenagon Asset Management S.A., Pensionfund DSM Netherlands, Pensionfund Sabic, Quantitative Systematic Strategies LLC, Robeco Institutional Asset Management B.V., FormulaFolio Investments LLC and Fisher Asset Management LLC. View Insider Buying and Selling for Colgate-Palmolive Company.

How do I buy Colgate-Palmolive Company stock?

Shares of Colgate-Palmolive Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Colgate-Palmolive Company's stock price today?

One share of Colgate-Palmolive Company stock can currently be purchased for approximately $72.32.

MarketBeat Community Rating for Colgate-Palmolive Company (NYSE CL)
Community Ranking:  1.4 out of 5 (star)
Outperform Votes:  238 (Vote Outperform)
Underperform Votes:  640 (Vote Underperform)
Total Votes:  878
MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Colgate-Palmolive Company (NYSE:CL) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 12 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $76.38 (5.62% upside)
Consensus Price Target History for Colgate-Palmolive Company (NYSE:CL)
Price Target History for Colgate-Palmolive Company (NYSE:CL)
Analysts' Ratings History for Colgate-Palmolive Company (NYSE:CL)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/16/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/11/2017SunTrust Banks, Inc.UpgradeHold -> Buy$65.00 -> $85.00N/AView Rating Details
10/8/2017Royal Bank Of CanadaReiterated RatingHold$74.00N/AView Rating Details
9/28/2017Jefferies Group LLCReiterated RatingHold$79.00LowView Rating Details
9/25/2017Morgan StanleyUpgradeEqual Weight -> Overweight$75.00 -> $84.00HighView Rating Details
9/14/2017MacquarieInitiated CoverageNeutral -> Neutral$76.00LowView Rating Details
7/24/2017Deutsche Bank AGReiterated RatingHold$75.00LowView Rating Details
7/24/2017Wells Fargo & CoReiterated RatingMarket PerformLowView Rating Details
5/31/2017Bank of America CorporationBoost Price TargetBuy$78.00 -> $80.00LowView Rating Details
4/7/2017Citigroup Inc.Reiterated RatingNeutral$75.00 -> $76.00LowView Rating Details
3/21/2017J P Morgan Chase & CoInitiated CoverageNeutral -> Neutral$77.00LowView Rating Details
2/21/2017BNP ParibasUpgradeNeutral -> OutperformN/AView Rating Details
2/18/2017Barclays PLCSet Price TargetHold$75.00N/AView Rating Details
2/3/2017B. RileyReiterated RatingNeutral$74.00N/AView Rating Details
1/30/2017Stifel NicolausLower Price TargetHold$75.00 -> $70.00N/AView Rating Details
1/25/2017Berenberg BankInitiated CoverageHold$68.00N/AView Rating Details
7/29/2016Exane BNP ParibasDowngradeOutperform -> NeutralN/AView Rating Details
7/15/2016Goldman Sachs Group, Inc. (The)Reiterated RatingNeutral$74.00 -> $76.00N/AView Rating Details
6/1/2016Atlantic SecuritiesInitiated CoverageOverweightN/AView Rating Details
2/26/2016Sterne Agee CRTDowngradeBuy -> NeutralN/AView Rating Details
1/29/2016Canaccord GenuityReiterated RatingHold$66.50N/AView Rating Details
11/26/2015ArgusUpgradeHold -> BuyN/AView Rating Details
11/4/2015Societe GeneraleBoost Price TargetHold$68.00 -> $71.00N/AView Rating Details
11/2/2015S&P Equity ResearchReiterated RatingHold$69.00N/AView Rating Details
(Data available from 10/20/2015 forward)


Earnings History for Colgate-Palmolive Company (NYSE:CL)
Earnings by Quarter for Colgate-Palmolive Company (NYSE:CL)
Earnings History by Quarter for Colgate-Palmolive Company (NYSE CL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2017$0.73N/AView Earnings Details
7/21/2017Q2 2017$0.72$0.72$3.89 billion$3.83 billionViewN/AView Earnings Details
4/28/2017Q1 17$0.66$0.67$3.80 billion$3.76 billionViewN/AView Earnings Details
1/27/2017Q416$0.75$0.75$3.87 billion$3.72 billionViewN/AView Earnings Details
10/27/2016Q316$0.73$0.73$3.94 billion$3.87 billionViewListenView Earnings Details
7/28/2016Q216$0.69$0.70$3.86 billion$3.85 billionViewListenView Earnings Details
4/28/2016Q116$0.63$0.63$3.76 billion$3.76 billionViewListenView Earnings Details
1/29/2016Q415$0.72$0.73$3.94 billion$3.90 billionViewListenView Earnings Details
10/30/2015Q315$0.72$0.72$4.08 billion$4.00 billionViewListenView Earnings Details
7/30/2015Q215$0.70$0.70$4.07 billion$4.07 billionViewListenView Earnings Details
4/30/2015Q115$0.66$0.66$4.06 billion$4.07 billionViewN/AView Earnings Details
1/29/2015Q414$0.75$0.76$4.24 billion$4.22 billionViewN/AView Earnings Details
10/24/2014Q314$0.75$0.76$4.44 billion$4.38 billionViewListenView Earnings Details
7/31/2014Q214$0.73$0.73$4.41 billion$4.35 billionViewN/AView Earnings Details
4/25/2014Q114$0.68$0.68$4.32 billion$4.33 billionViewN/AView Earnings Details
1/31/2014Q413$0.74$0.75$4.40 billion$4.36 billionViewN/AView Earnings Details
10/24/2013Q313$0.73$0.73$4.46 billion$4.40 billionViewN/AView Earnings Details
7/25/2013Q2 2013$0.70$0.70$4.39 billion$4.35 billionViewN/AView Earnings Details
4/25/2013Q1 2013$1.32$1.32$4.30 billion$4.32 billionViewN/AView Earnings Details
1/31/2013Q4 2012$1.40$1.41$4.31 billion$4.29 billionViewN/AView Earnings Details
10/25/2012$1.39$1.38ViewN/AView Earnings Details
7/26/2012$1.33$1.33ViewN/AView Earnings Details
4/26/2012$1.24$1.24ViewN/AView Earnings Details
1/26/2012$1.30$1.30ViewN/AView Earnings Details
10/27/2011$1.30$1.31ViewN/AView Earnings Details
7/28/2011$1.25$1.26ViewN/AView Earnings Details
4/28/2011$1.16$1.16ViewN/AView Earnings Details
1/27/2011$1.23$1.24ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Colgate-Palmolive Company (NYSE:CL)
2017 EPS Consensus Estimate: $2.96
2018 EPS Consensus Estimate: $3.15
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.66$0.69$0.67
Q2 20174$0.72$0.77$0.74
Q3 20174$0.71$0.80$0.75
Q4 20174$0.78$0.85$0.80
Q1 20181$0.77$0.77$0.77
Q2 20181$0.76$0.76$0.76
Q3 20182$0.76$0.81$0.79
Q4 20182$0.82$0.84$0.83
(Data provided by Zacks Investment Research)


Current Dividend Information for Colgate-Palmolive Company (NYSE:CL)
Next Dividend:11/15/2017
Annual Dividend:$1.60
Dividend Yield:2.21%
Dividend Growth:5.20% (3 Year Average)
Payout Ratio:59.48% (Trailing 12 Months of Earnings)
55.17% (Based on This Year's Estimates)
51.12% (Based on Next Year's Estimates)
Track Record:53 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Colgate-Palmolive Company (NYSE:CL)

Dividend History by Quarter for Colgate-Palmolive Company (NYSE CL)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Colgate-Palmolive Company (NYSE:CL)
Insider Ownership Percentage: 1.02%
Institutional Ownership Percentage: 73.09%
Insider Trades by Quarter for Colgate-Palmolive Company (NYSE:CL)
Institutional Ownership by Quarter for Colgate-Palmolive Company (NYSE:CL)
Insider Trades by Quarter for Colgate-Palmolive Company (NYSE:CL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2017Patricia VerduinInsiderSell3,833$71.45$273,867.85View SEC Filing  
8/10/2017John J HustonSVPSell14,000$71.36$999,040.00View SEC Filing  
8/7/2017Franck J MoisonVice ChairmanSell35,000$71.52$2,503,200.00View SEC Filing  
8/3/2017Dennis J HickeyCFOSell73,872$71.80$5,304,009.60View SEC Filing  
8/1/2017Ellen M HancockDirectorSell5,057$71.91$363,648.87View SEC Filing  
7/27/2017John T CahillDirectorSell8,000$72.47$579,760.00View SEC Filing  
7/27/2017Justin SkalaCOOSell74,374$72.51$5,392,858.74View SEC Filing  
7/17/2017Patricia VerduinInsiderSell3,833$72.41$277,547.53View SEC Filing  
6/15/2017Patricia VerduinInsiderSell3,833$75.67$290,043.11View SEC Filing  
5/10/2017John J HustonSVPSell14,000$71.53$1,001,420.00View SEC Filing  
5/8/2017Richard J KoganDirectorSell8,000$71.92$575,360.00View SEC Filing  
4/17/2017Daniel B MarsiliVPSell14,000$73.97$1,035,580.00View SEC Filing  
4/17/2017Patricia VerduinInsiderSell3,833$73.72$282,568.76View SEC Filing  
2/3/2017Stephen I SadoveDirectorSell8,000$66.00$528,000.00View SEC Filing  
1/17/2017Patricia VerduinInsiderSell3,833$65.99$252,939.67View SEC Filing  
1/9/2017Jennifer DanielsInsiderSell868$66.62$57,826.16View SEC Filing  
12/15/2016Patricia VerduinInsiderSell3,834$65.66$251,740.44View SEC Filing  
12/13/2016Jennifer DanielsInsiderSell7,072$66.78$472,268.16View SEC Filing  
10/17/2016Patricia VerduinInsiderSell3,834$72.39$277,543.26View SEC Filing  
9/15/2016Patricia VerduinInsiderSell3,834$71.85$275,472.90View SEC Filing  
8/11/2016Franck J MoisonCOOSell15,000$75.16$1,127,400.00View SEC Filing  
8/10/2016John J HustonSVPSell14,000$74.93$1,049,020.00View SEC Filing  
8/10/2016Richard J KoganDirectorSell8,000$74.66$597,280.00View SEC Filing  
8/8/2016Stephen I SadoveDirectorSell8,803$74.28$653,886.84View SEC Filing  
8/2/2016Ellen M HancockDirectorSell4,584$74.82$342,974.88View SEC Filing  
8/2/2016Noel R WallaceCOOSell78,849$74.69$5,889,231.81View SEC Filing  
7/15/2016Patricia VerduinCTOSell3,666$74.98$274,876.68View SEC Filing  
6/15/2016Patricia VerduinCTOSell3,666$72.19$264,648.54View SEC Filing  
5/16/2016Patricia VerduinCTOSell3,666$71.59$262,448.94View SEC Filing  
5/11/2016Ellen M HancockDirectorSell4,566$71.85$328,067.10View SEC Filing  
5/11/2016John J HustonVPSell14,000$72.23$1,011,220.00View SEC Filing  
5/11/2016Justin SkalaCOOSell89,200$72.17$6,437,564.00View SEC Filing  
5/9/2016Noel R WallaceCOOSell8,931$72.06$643,567.86View SEC Filing  
5/5/2016Delia H ThompsonVPSell40,000$72.08$2,883,200.00View SEC Filing  
5/3/2016John T CahillDirectorSell16,000$72.30$1,156,800.00View SEC Filing  
5/3/2016Noel R WallaceCOOSell60,000$72.16$4,329,600.00View SEC Filing  
5/3/2016Victoria L DolanVPSell19,334$71.76$1,387,407.84View SEC Filing  
4/15/2016Patricia VerduinCTOSell3,666$70.83$259,662.78View SEC Filing  
3/8/2016Delia H ThompsonVPSell1,698$67.36$114,377.28View SEC Filing  
3/8/2016Dennis J HickeyCFOSell5,420$67.36$365,091.20View SEC Filing  
3/8/2016Franck J MoisonCOOSell6,661$67.36$448,684.96View SEC Filing  
3/8/2016Ian M CookCEOSell25,238$67.36$1,700,031.68View SEC Filing  
3/8/2016Mukul DeorasCMOSell1,325$67.36$89,252.00View SEC Filing  
3/8/2016Noel R WallaceInsiderSell5,238$67.36$352,831.68View SEC Filing  
3/8/2016Patricia VerduinCTOSell1,953$67.36$131,554.08View SEC Filing  
2/17/2016Dennis J. HickeyCFOSell50,697$67.05$3,399,233.85View SEC Filing  
2/16/2016Fabian T. GarciaCOOSell145,000$65.72$9,529,400.00View SEC Filing  
2/16/2016Patricia VerduinCTOSell3,666$66.58$244,082.28View SEC Filing  
2/11/2016John J. HustonVPSell14,000$64.89$908,460.00View SEC Filing  
2/10/2016Richard J. KoganDirectorSell8,000$66.27$530,160.00View SEC Filing  
2/5/2016Delano E LewisDirectorSell200$65.92$13,184.00View SEC Filing  
1/15/2016Patricia VerduinCTOSell3,666$62.37$228,648.42View SEC Filing  
1/11/2016Jennifer DanielsInsiderSell837$62.85$52,605.45View SEC Filing  
8/14/2015Ellen M HancockDirectorSell3,637$67.89$246,915.93View SEC Filing  
6/15/2015Daniel B MarsiliVPSell14,000$65.65$919,100.00View SEC Filing  
6/15/2015Patricia VerduinCTOSell3,333$65.64$218,778.12View SEC Filing  
5/15/2015Delano E LewisDirectorSell6,023$68.51$412,635.73View SEC Filing  
4/15/2015Daniel B MarsiliVPSell14,000$69.93$979,020.00View SEC Filing  
4/15/2015Patricia VerduinCTOSell3,333$69.89$232,943.37View SEC Filing  
3/9/2015Dennis J HickeyCFOSell18,224$69.49$1,266,385.76View SEC Filing  
3/9/2015Fabian T GarciaCOOSell10,137$69.49$704,420.13View SEC Filing  
3/9/2015Noel R WallaceInsiderSell6,638$69.49$461,274.62View SEC Filing  
3/9/2015Patricia VerduinCTOSell2,828$69.49$196,517.72View SEC Filing  
3/9/2015Victoria L DolanVPSell2,834$69.49$196,934.66View SEC Filing  
2/10/2015Ellen M HancockDirectorSell4,011$69.38$278,283.18View SEC Filing  
2/10/2015John J HustonVPSell14,000$69.19$968,660.00View SEC Filing  
2/5/2015Delano E LewisDirectorSell9,226$69.05$637,055.30View SEC Filing  
1/27/2015Andrew D HendryVice ChairmanSell10,000$65.29$652,900.00View SEC Filing  
1/15/2015Patricia VerduinCTOSell3,333$68.66$228,843.78View SEC Filing  
12/23/2014Andrew D HendryVice ChairmanSell10,000$70.39$703,900.00View SEC Filing  
12/15/2014Patricia VerduinCTOSell3,333$68.65$228,810.45View SEC Filing  
11/25/2014Andrew D HendryVice ChairmanSell10,000$67.94$679,400.00View SEC Filing  
11/25/2014Larisa HarrisonDirectorBuy2,000$0.29$570.00
11/17/2014Patricia VerduinCTOSell3,333$67.48$224,910.84View SEC Filing  
11/11/2014Andrew D HendryVice ChairmanSell10,000$68.46$684,600.00View SEC Filing  
10/29/2014Nigel BurtonCMOSell2,323$65.89$153,062.47View SEC Filing  
10/28/2014Andrew D HendryVice ChairmanSell10,000$66.32$663,200.00View SEC Filing  
9/23/2014Andrew D HendryVice ChairmanSell10,000$65.50$655,000.00View SEC Filing  
9/15/2014Patricia VerduinCTOSell3,337$64.27$214,468.99View SEC Filing  
9/9/2014Andrew D HendryVice ChairmanSell10,000$63.52$635,200.00View SEC Filing  
8/18/2014Delia H ThompsonVPSell40,000$64.75$2,590,000.00View SEC Filing  
8/18/2014Justin SkalaInsiderSell41,525$64.52$2,679,193.00View SEC Filing  
8/8/2014Franck J MoisonCOOSell24,888$64.73$1,611,000.24View SEC Filing  
8/5/2014Franck J MoisonCOOSell41,654$63.91$2,662,107.14View SEC Filing  
7/22/2014Andrew D HendryVice ChairmanSell10,000$68.73$687,300.00View SEC Filing  
7/15/2014Daniel B MarsiliVPSell15,500$69.71$1,080,505.00View SEC Filing  
7/10/2014Patricia VerduinCTOSell2,291$69.66$159,591.06View SEC Filing  
7/8/2014Andrew D HendryVice ChairmanSell10,000$68.64$686,400.00View SEC Filing  
6/24/2014Andrew D HendryVice ChairmanSell10,000$67.72$677,200.00View SEC Filing  
6/16/2014Daniel B MarsiliVPSell15,500$67.59$1,047,645.00View SEC Filing  
6/10/2014Andrew D HendryVice ChairmanSell6,000$68.57$411,420.00View SEC Filing  
5/27/2014Andrew D HendryVice ChairmanSell6,000$66.90$401,400.00View SEC Filing  
5/15/2014Patricia VerduinCTOSell2,000$66.86$133,720.00View SEC Filing  
5/13/2014Andrew HendryVice ChairmanSell6,000$67.25$403,500.00View SEC Filing  
5/13/2014Delano LewisDirectorSell2,100$67.19$141,099.00View SEC Filing  
5/13/2014Dennis HickeyCFOSell51,352$67.18$3,449,827.36View SEC Filing  
5/12/2014Daniel MarsiliVPSell15,500$67.37$1,044,235.00View SEC Filing  
5/7/2014Stephen FogartyInsiderSell11,000$67.23$739,530.00View SEC Filing  
5/2/2014Ronald MartinVPSell3,000$67.13$201,390.00View SEC Filing  
5/1/2014Delano LewisDirectorSell5,000$67.07$335,350.00View SEC Filing  
5/1/2014Fabian GarciaCOOSell122,000$67.04$8,178,880.00View SEC Filing  
4/22/2014Andrew HendryVice ChairmanSell6,000$66.89$401,340.00View SEC Filing  
4/15/2014Patricia VerduinCTOSell2,000$66.09$132,180.00View SEC Filing  
4/8/2014Andrew HendryVice ChairmanSell6,000$65.03$390,180.00View SEC Filing  
3/17/2014Patricia VerduinCTOSell2,000$64.06$128,120.00View SEC Filing  
2/28/2014Stephen FogartyInsiderSell12,000$63.10$757,200.00View SEC Filing  
1/28/2014Andrew HendryVice ChairmanSell6,000$62.31$373,860.00View SEC Filing  
12/24/2013Andrew HendryVice ChairmanSell6,000$64.80$388,800.00View SEC Filing  
12/16/2013Patricia VerduinCTOSell2,000$64.14$128,280.00View SEC Filing  
10/29/2013Michael CorboVPSell15,770$65.00$1,025,050.00View SEC Filing  
10/29/2013Nigel BurtonCMOSell19,862$65.51$1,301,159.62View SEC Filing  
10/29/2013Stephen J FogartyInsiderSell12,000$65.67$788,040.00View SEC Filing  
10/22/2013Andrew D HendryVice ChairmanSell6,000$62.40$374,400.00View SEC Filing  
10/15/2013Patricia VerduinCTOSell2,000$61.51$123,020.00View SEC Filing  
10/8/2013Andrew HendryVice ChairmanSell6,000$59.35$356,100.00View SEC Filing  
9/24/2013Andrew HendryVice ChairmanSell6,000$60.00$360,000.00View SEC Filing  
9/17/2013Michael CorboVPSell1,108$59.62$66,058.96View SEC Filing  
9/17/2013Nigel BurtonCMOSell2,015$59.62$120,134.30View SEC Filing  
9/17/2013Patricia VerduinCTOSell3,649$59.71$217,881.79View SEC Filing  
9/17/2013Stephen FogartyInsiderSell1,035$59.62$61,706.70View SEC Filing  
9/10/2013Andrew D HendryVice ChairmanSell6,000$58.79$352,740.00View SEC Filing  
8/15/2013Franck MoisonCOOSell12,400$60.28$747,472.00View SEC Filing  
8/15/2013Guillenchmidt Alec DeInsiderSell3,888$60.28$234,368.64View SEC Filing  
8/15/2013Patricia VerduinCTOSell2,000$60.28$120,560.00View SEC Filing  
8/12/2013Delia ThompsonVPSell30,950$60.73$1,879,593.50View SEC Filing  
8/12/2013Stephen FogartyInsiderSell12,000$60.64$727,680.00View SEC Filing  
8/8/2013Nigel BurtonCMOSell18,667$61.06$1,139,807.02View SEC Filing  
8/6/2013Elaine PaikVPSell7,141$60.94$435,172.54View SEC Filing  
8/6/2013Mukul DeorasInsiderSell8,417$60.90$512,595.30View SEC Filing  
7/31/2013Ronald T MartinVPSell1,800$60.27$108,486.00View SEC Filing  
7/30/2013Michael CorboVPSell10,000$60.21$602,100.00View SEC Filing  
7/15/2013Franck J MoisonCOOSell12,400$59.05$732,220.00View SEC Filing  
7/15/2013Justin SkalaInsiderSell4,822$59.03$284,642.66View SEC Filing  
7/15/2013Michael CorboVPSell2,000$59.13$118,260.00View SEC Filing  
6/17/2013Franck J MoisonCOOSell12,400$59.18$733,832.00View SEC Filing  
6/17/2013Guillenchmidt Alec DeInsiderSell3,888$59.09$229,741.92View SEC Filing  
6/17/2013Michael CorboVPSell2,000$59.09$118,180.00View SEC Filing  
6/4/2013Andrew D HendryVice ChairmanSell4,000$58.84$235,360.00View SEC Filing  
5/21/2013Andrew D HendryVice ChairmanSell6,000$61.63$369,780.00View SEC Filing  
5/15/2013Franck J MoisonCOOSell6,200$122.66$760,492.00View SEC Filing  
5/15/2013Guillenchmidt Alec DeInsiderSell1,944$122.66$238,451.04View SEC Filing  
5/15/2013Michael CorboVPSell1,000$122.66$122,660.00View SEC Filing  
5/13/2013Rosemary NelsonVPSell14,000$121.00$1,694,000.00View SEC Filing  
5/10/2013Dennis J HickeyCFOSell64,000$120.54$7,714,560.00View SEC Filing  
5/7/2013Andrew D HendryVice ChairmanSell6,000$120.37$722,220.00View SEC Filing  
4/30/2013Nigel BurtonCMOSell80,334$118.68$9,534,039.12View SEC Filing  
2/26/2013Daniel B MarsiliVPSell12,252$113.66$1,392,562.32View SEC Filing  
2/26/2013Justin SkalaInsiderSell5,894$113.64$669,794.16View SEC Filing  
12/4/2012Andrew D HendryVice ChairmanSell6,000$108.00$648,000.00View SEC Filing  
10/2/2012Andrew D HendryVice ChairmanSell6,000$108.27$649,620.00View SEC Filing  
9/4/2012Andrew D HendryVice ChairmanSell6,000$106.16$636,960.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Colgate-Palmolive Company (NYSE:CL)
Latest Headlines for Colgate-Palmolive Company (NYSE:CL)
DateHeadline logoColgate-Palmolive Company (CL) Set to Announce Earnings on Friday - October 20 at 1:08 AM logoColgate-Palmolive Company (CL) Ex-Dividend Date Scheduled for October - October 19 at 10:43 PM logoDividend Coverage: This Consumer Goods Company has Paid Uninterrupted Dividend since 1895 Dividend; Will Trade Ex-Dividend on October 20, 2017 - October 19 at 5:41 PM logoEx-Dividend Reminder: Hormel Foods, Ford Motor and Colgate-Palmolive - October 18 at 6:35 PM logoHow Are Colgate-Palmolive’s Regional Sales Trending? - October 18 at 6:35 PM logoCould Colgate-Palmolive’s Profit Margins Improve in 3Q17? - October 18 at 6:35 PM logoWhat Analysts Are Suggesting for CL Stock - October 18 at 6:35 PM logoKeyCorp Brokers Boost Earnings Estimates for Colgate-Palmolive Company (CL) - October 18 at 9:56 AM logoColgate-Palmolive (CL) vs. Nu Skin Enterprises (NUS) Financial Review - October 18 at 12:14 AM logoCould Colgate-Palmolive Stock Rise on 3Q17 Results? - October 17 at 5:58 PM logoCould Colgate-Palmolive Exceed Its 3Q17 Earnings Estimate? - October 17 at 5:58 PM logoColgate-Palmolive's (CL) "Hold" Rating Reaffirmed at KeyCorp - October 17 at 10:24 AM logoConsumer Staples: This Could Get Ugly - October 16 at 6:00 PM logoComparing DS Healthcare Group (DSKX) and Colgate-Palmolive (CL) - October 16 at 10:30 AM logoColgate-Palmolive Company (CL) Stock Rating Upgraded by SunTrust Banks, Inc. - October 16 at 12:50 AM logoWhy SunTrust Upgraded Colgate-Palmolive Stock - October 12 at 6:03 PM logoColgate-Palmolive Webcasts 2017 Third Quarter Earnings Conference Call October 27, 2017 – 11:00 a.m. ET - October 12 at 6:03 PM logoSunTrust Banks Brokers Lift Earnings Estimates for Colgate-Palmolive Company (CL) - October 12 at 1:32 PM logoSunTrust Robinson Humphrey Upgrades Colgate-Palmolive Company (CL) to Buy - October 11 at 11:48 PM logoColgate-Palmolive Co. (CL) Is Up Sharply Following Upgrade - October 11 at 11:48 PM logoCramer: These Research Upgrades Are Actually Having an Impact - October 11 at 11:48 PM logoSunTrust Robinson Humphrey Upgrades Colgate-Palmolive Company (CL) to Buy - - October 11 at 6:45 PM logoConsumer Stocks Rally for a Second Day as Kroger, Colgate Lead the Way - October 11 at 6:44 PM logoColgate: The Return of the Emerging Market Consumer - October 11 at 6:44 PM logoWhat Is The Best Consumer Staple Stock At The Moment? - October 10 at 6:26 PM logoColgate-Palmolive Company (CL) Stock Rating Reaffirmed by Royal Bank Of Canada - October 8 at 6:02 AM logo$3.92 Billion in Sales Expected for Colgate-Palmolive Company (CL) This Quarter - October 5 at 6:48 AM logoColgate-Palmolive Company (CL) Given Average Rating of "Hold" by Brokerages - October 4 at 6:02 PM logoMorgan Stanley Catches Flack For Colgate-Palmolive Upgrade - Benzinga - October 2 at 10:09 PM logoMorgan Stanley Catches Flack For Colgate-Palmolive Upgrade - October 2 at 10:09 PM logoWhat Analysts Recommend for Colgate-Palmolive - October 2 at 5:07 PM logoStock Traders Purchase Large Volume of Put Options on Colgate-Palmolive (CL) - September 30 at 2:32 AM logoWill Colgate's Strategic Initiatives Help Counter Sales Woes? - September 29 at 4:16 PM logoColgate-Palmolive Company (CL) Earns "Hold" Rating from Jefferies Group LLC - September 28 at 8:01 AM logoColgate-Palmolive Stock Could Reach $84 - September 27 at 7:28 PM logoColgate-Palmolive Company (CL) Declares Quarterly Dividend of $0.40 - September 26 at 5:20 PM logoWhy Colgate-Palmolive Company (CL) Shares Are Popping Today - September 25 at 3:33 PM logoWhy Colgate-Palmolive Company (CL) Shares Are Popping Today - - September 25 at 3:33 PM logoDon't Brush Off An Opportunity To Buy Colgate-Palmolive Right Now - September 25 at 1:40 PM logoUPDATE: Morgan Stanley Upgrades Colgate-Palmolive Company (CL) to Overweight - September 25 at 12:29 PM logoColgate-Palmolive Co. (CL) Has Risen To A 2-Month High After Upgrade - September 25 at 12:29 PM logoColgate-Palmolive's stock surges as analyst sees 'rare opportunity' to buy - September 25 at 12:29 PM logoMorgan Stanley Upgrades Colgate-Palmolive Company (CL) to Overweight - September 25 at 7:56 AM logoShould You Buy This Dividend Aristocrat For Your Retirement Portfolio? - September 23 at 5:04 PM logoFinancial Comparison: DS Healthcare Group (DSKX) and Colgate-Palmolive (CL) - September 23 at 2:26 AM logoColgate-Palmolive Co. breached its 50 day moving average in a Bearish Manner : CL-US : September 22, 2017 - September 22 at 4:14 PM logoColgate-Palmolive Co. Breaks Below 200-Day Moving Average - Notable for CL - September 21 at 5:06 PM logoShort Interest in Colgate-Palmolive Company (CL) Drops By 36.6% - September 19 at 1:44 AM logoColgate-Palmolive: Sustaining The Dividend, For Now - September 17 at 2:56 AM logoWhat Does Colgate-Palmolive Company’s (CL) Share Price Indicate? - September 15 at 5:38 PM



Colgate-Palmolive Company (CL) Chart for Friday, October, 20, 2017

This page was last updated on 10/20/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.